ArticleDigestive diseases and sciences2025
Technical Feasibility and Safety of a Novel Device for Simultaneous Double Guidewire Insertion and Tract Dilation During Interventional EUS.
Article in Digestive diseases and sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mid-route pancreatic duct seeking during endoscopic ultrasound-guided pancreatic duct drainage.Endoscopy · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimInterventional endoscopic ultrasound (I-EUS) has been developed as an alternative technique. To prevent these adverse events, sufficient tract dilation using by one device or double guidewire technique (DGWT) is useful. For application of the DGWT, we developed a novel double lumen dilator (DLD). This study evaluated the technical feasibility of I-EUS using the DLD.
methodThe primary outcome of this study was the technical success rate of DLD insertion into the target site. The secondary outcomes were adverse events associated with the procedure.
resultsA total of consecutive 19 patients who underwent I-EUS using DLD as dilation device between November 2024 and December 2024 were enrolled in this study. The technical success rate of DLD insertion was 94.7% (18/19). Mean procedure time was 14.4 min. Among the 18 patients who underwent successful DLD insertion, stent deployment was successfully performed. Stent misdeployment was observed in one patient during EUS-guided hepaticogastrostomy, and the dislocated metal stent could not recovered. However, a plastic stent was successfully deployed by the DGWT.
conclusionsThe DLD allows DGWT and tract dilation to be performed as a single step, and therefore, might play a role in the safety and efficacy of the I-EUS procedure.
Indexed as
Identifiers
40711744What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.